astragaloside a has been researched along with Chronic Kidney Failure in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, Z; Jia, Q; Sun, Z; Wang, X; Xia, J; Xue, L; Zhang, L; Zhou, L | 1 |
| Bao, X; Dong, P; Sun, Z; Wang, X; Xia, J; Xu, Z; Xue, L; Zhou, L | 1 |
2 other study(ies) available for astragaloside a and Chronic Kidney Failure
| Article | Year |
|---|---|
Pharmacokinetic-pharmacodynamic modeling of the active components of Shenkang injection in rats with chronic renal failure and its protective effect on damaged renal cells.
Topics: Animals; Drugs, Chinese Herbal; Emodin; Fibrosis; Kidney; Kidney Failure, Chronic; Rats; Rats, Sprague-Dawley; Renal Insufficiency, Chronic | 2023 |
Study on the mechanism of Shenkang injection in the treatment of chronic renal failure based on the strategy of "Network pharmacology-Molecular docking-Key target validation".
Topics: Animals; Drugs, Chinese Herbal; Emodin; Kidney Failure, Chronic; Molecular Docking Simulation; Network Pharmacology; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Renal Insufficiency, Chronic | 2023 |